NCT07670065

Brief Summary

This study investigates whether direct transfer to an emergency stroke unit equipped with NeuAngio-CT reduces time to endovascular reperfusion in patients with acute ischemic stroke and suspected intracranial large-vessel occlusion.Those aged 18-60 years with acute ischemic stroke who are eligible for endovascular thrombectomy within 24 hours of symptom onset will be enrolled. Participants will be randomly assigned to one of two groups. In the intervention group, participants will undergo femoral or radial artery puncture, followed by intracranial and cervical CT angiography with intra-arterial contrast injection (iacCTA) performed using the sliding-rail NeuAngio-CT, and subsequent thrombectomy guided by fused CTA-DSA images. In the control group, participants will receive intracranial and cervical CT angiography with intra-venous contrast injection and the thrombectomy will guided by standard DSA imaging without use of the sliding-rail CT. The primary endpoint is puncture-to-successful-reperfusion time (PRT); if successful reperfusion is not achieved, the end-of-procedure time will be used.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
232

participants targeted

Target at P25-P50 for phase_3

Timeline
14mo left

Started Jun 2026

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress11%
Jun 2026Oct 2027

First Submitted

Initial submission to the registry

May 24, 2026

Completed
15 days until next milestone

Study Start

First participant enrolled

June 8, 2026

Completed
18 days until next milestone

First Posted

Study publicly available on registry

June 26, 2026

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2027

Last Updated

June 26, 2026

Status Verified

June 1, 2026

Enrollment Period

1.2 years

First QC Date

May 24, 2026

Last Update Submit

June 21, 2026

Conditions

Keywords

Sliding CT/DSAOne-stop ManagementMechanical ThrombectomyEmergency Stroke Care

Outcome Measures

Primary Outcomes (1)

  • Puncture-to-reperfusion time (PRT)

    Time from puncture completion to successful recanalization; if recanalization is not achieved, the end of procedure is used instead.

    immediately after the intervention

Secondary Outcomes (8)

  • Intervention-to-reperfusion time (IRT)

    immediately after the intervention

  • Procedure duration

    immediately after the intervention

  • Puncture completion-to-first-recanalization time

    immediately after the intervention

  • First-pass recanalization rate

    immediately after the intervention

  • Contrast volume from puncture to end of procedure

    immediately after the intervention

  • +3 more secondary outcomes

Study Arms (2)

Direct Angio Suite Acute Stroke Intervention With CT/DSA Hybrid Emergency Stroke Unit

EXPERIMENTAL

Participants will undergo femoral or radial artery puncture, followed by intracranial and cervical CT angiography with intra-arterial contrast injection (iacCTA) performed using the sliding-rail NeuAngio-CT, and subsequent thrombectomy guided by fused CTA-DSA images.

Device: Direct Angio Suite Acute Stroke Intervention With CT/DSA Hybrid Emergency Stroke Unit

Conventional Thrombectomy

PLACEBO COMPARATOR

Participants will receive intracranial and cervical CT angiography with intra-venous contrast injection and the thrombectomy will guided by standard DSA imaging without use of the sliding-rail CT.

Device: Conventional Thrombectomy

Interventions

Participants will undergo femoral or radial artery puncture, followed by intracranial and cervical CT angiography with intra-arterial contrast injection (iacCTA) performed using the sliding-rail NeuAngio-CT, and subsequent thrombectomy guided by fused CTA-DSA images.

Direct Angio Suite Acute Stroke Intervention With CT/DSA Hybrid Emergency Stroke Unit

Participants will receive intracranial and cervical CT angiography with intra-venous contrast injection and the thrombectomy will guided by standard DSA imaging without use of the sliding-rail CT.

Conventional Thrombectomy

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-60 years;
  • Clinical diagnosis of acute ischemic stroke eligible for immediate endovascular treatment;
  • Time from symptom onset or last known well ≤ 24 hours;
  • Intravenous intracranial and cervical CT angiography completed;
  • Confirmed target vessel occlusion amenable to endovascular intervention based on intravenous intracranial and cervical CT angiography findings;
  • Written informed consent obtained from the patient or their legally authorized representative.

You may not qualify if:

  • Known contrast agent allergy;
  • Renal insufficiency with GFR (glomerular filtration rate) \< 45 mL/min/1.73 m²;
  • History of kidney transplantation;
  • Concomitant diabetes mellitus with current use of metformin;
  • Women who are pregnant, breastfeeding, or have a positive pregnancy test at admission;
  • Refractory hypertension (defined as systolic blood pressure ≥ 185 mmHg or diastolic blood pressure ≥ 110 mmHg) (Note: patients may be enrolled if blood pressure is successfully reduced and maintained at an acceptable level with antihypertensive therapy);
  • Intracranial space-occupying lesion or other conditions deemed unsuitable for endovascular intervention on imaging;
  • Any other serious comorbidity or complication that may interfere with study conduct or evaluation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Tiantan Hospital

Beijing, China

Location

MeSH Terms

Conditions

Ischemic Stroke

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Zeguang Ren, Dr.

    Beijing Tiantan Hospital

    STUDY DIRECTOR

Central Study Contacts

Yongjun Wang, Dr.

CONTACT

Xuewei Xie, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 24, 2026

First Posted

June 26, 2026

Study Start

June 8, 2026

Primary Completion (Estimated)

August 15, 2027

Study Completion (Estimated)

October 15, 2027

Last Updated

June 26, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations